Pathogenesis of coeliac disease: Implications for treatment

World Journal of Gastroenterology

Volumn 7, Issue 6, 2001, Pages 772-776

  Fraser, J S ^a   Ciclitira, P J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN; GLUTEN; PEPTIDE; PREDNISOLONE; STEROID;

CELIAC DISEASE; CEREAL; DRUG ABSORPTION; EPIDEMIOLOGICAL DATA; FOOD COMPOSITION; FOOD INTAKE; GLUTEN FREE DIET; HISTOPATHOLOGY; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; NONHUMAN; PATHOGENESIS; PREVALENCE; REVIEW; SLOW RELEASE FORMULATION;

EID: 0035680213     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i6.772     Document Type: Review

References (49)

1. Changing features of coeliac disease
2. The coeliac iceberg
3. High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies
4. Where have all the American celiacs gone?
5. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects
6. Clinical and pathological spectrum of coeliac disease - Active, silent, latent, potential
7. Mucosal pathology in gluten sensitivity
8. N-terminal amino acid sequencing of prolamins of wheat and related species
9. Coeliac disease IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease
10. Cereal proteins and coeliac disease
11. Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: The role of trace amounts of gluten and non-gluten food intolerances
12. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten
13. Coeliac disease II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease
14. Coeliac disease (in regard to gluten intolerance)
15. Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease
16. Oats and barley toxicity in coeliac patients
17. The place of oats in the coeliac diet
18. A comparison of diets with and without oats in adults with celiac disease
19. An analysis of cereals that react with serum antibodies in patients with coeliac disease
20. Western immunoblotting of cereal proteins with monoclonal antibodies to wheat gliadin to investigate coeliac disease
21. Seed storage proteins: Structures and biosynthesis
22. Wheat peptide challenge in coeliac disease
23. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
24. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase
25. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
26. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin
27. Coeliac disease: Previous family studies
28. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')
29. Gluten sensitive enteropathy in Spain: Genetic and environmental factors
30. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer
31. Celiac disease is associated with an extended HLA-DR3 haplotype which includes HLA-DPw1
32. HLA class II alleles associated with celiac disease susceptibility in a southern European population
33. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis
34. Gliadin-specific, HLA-DQ(alpha 1 * 0501, beta 1 * 0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients
35. Restriction fragment length polymorphism in HLA class II genes of Latin-American Caucasian celiac disease patients
36. Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility
37. Contribution of the MHC region to the familial risk of coeliac disease
38. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland
39. Genome search in celiac disease
40. A genome-wide family-based linkage study of coeliac disease
41. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease
42. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study
43. Immunocytes, enterocytes and the lamina propria: An immunopathological framework of coeliac disease
44. Detection and characterisation of anti-endomysial antibody in coeliac disease using human umbilical cord
45. Cytokine profile in coeliac disease
46. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules
47. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody
48. Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease
49. Failure of immunosuppressive therapy to prevent relapse of celiac sprue